Georgia vs Somalia: HIV/AIDS deaths averted by antiretroviral therapy
Georgia
391.52 deaths
in 2024
Somalia
336.41 deaths
in 2022
Georgia rank
97th
Somalia rank
98th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Georgia
- Somalia
How they compare
Georgia currently reports 391.52 deaths against 336.41 deaths in Somalia, a difference of 55.11 deaths.
That makes Georgia's figure about 1.2 times Somalia's.
The two have swapped places 3 times across 33 shared years of data; in 1990 it was Somalia ahead.
Georgia ranks 97th and Somalia ranks 98th of 157 countries.
Across the 4 decades both report, Georgia averaged higher in 1 and Somalia in 2.
Head to head by decade
| Decade | Georgia | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 21.22 deaths | 33.63 deaths | 12.41 deaths | Somalia |
| 2010s | 188.92 deaths | 264.05 deaths | 75.13 deaths | Somalia |
| 2020s | 343.87 deaths | 331.82 deaths | 12.04 deaths | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Georgia or Somalia?
- Georgia, at 391.52 deaths against 336.41 deaths in Somalia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Georgia and Somalia?
- 55.11 deaths, with Georgia ahead.
- How many years of comparable data are there for Georgia and Somalia?
- 33 years are reported by both, from 1990 to 2022.
- How do Georgia and Somalia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Georgia ranks 97th and Somalia ranks 98th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.